FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315487395> ?p ?o ?g. }

• W4315487395 abstract "Background: Gastric cancer (GC) is a multifactorial progressive disease with high mortality and heterogeneous prognosis. Effective prognostic biomarkers for GC were critically needed. Hippo signaling pathway is one of the critical mechanisms regulating the occurrence and development of GC, and has potential clinical application value for the prognosis and treatment of GC patients. However, there is no effective signature based on Hippo signaling pathway-related genes (HSPRGs) to predict the prognosis and treatment response of GC patients. Our study aimed to build a HSPRGs signature and explore its performance in improving prognostic assessment and drug therapeutic response in GC. Methods: Based on gene expression profiles obtained from The Cancer Genome Atlas (TCGA) database, we identified differentially expressed HSPRGs and conducted univariate and the least absolute shrinkage and selection operator (LASSO) Cox regression analysis to construct a multigene risk signature. Subsequently, the Kaplan-Meier curve and receiver operating characteristic (ROC) were performed to evaluate the predictive value of the risk signature in both training and validation cohort. Furthermore, we carried out univariate and multivariate Cox regression analysis to investigate the independent prognostic factors and establish a predictive nomogram. The enriched signaling pathways in risk signature were analyzed by gene set enrichment analysis (GSEA). Tumor immune dysfunction and exclusion (TIDE) and drug sensitivity analysis were performed to depict therapeutic response in GC. Results: In total, 38 differentially expressed HSPRGs were identified, and final four genes (DLG3, TGFB3, TGFBR1, FZD6) were incorporated to build the signature. The ROC curve with average 1-, 3-, and 5-year areas under the curve (AUC) equal to .609, .634, and .639. Clinical ROC curve revealed that risk signature was superior to other clinicopathological factors in predicting prognosis. Calibration curves and C-index (.655) of nomogram showed excellent consistency. Besides, in the immunotherapy analysis, exclusion (p < 2.22 × 10-16) and microsatellite instability (p = .0058) performed significantly differences. Finally, our results suggested that patients in the high-risk group were more sensitive to specific chemotherapeutic agents. Conclusion: Results support the hypothesis that Hippo-related signature is a novel prognostic biomarker and predictor, which could help optimize GC prognostic stratification and inform clinical medication decisions." @default.
• W4315487395 created "2023-01-11" @default.
• W4315487395 creator A5005196775 @default.
• W4315487395 creator A5007290715 @default.
• W4315487395 creator A5009380236 @default.
• W4315487395 creator A5022499603 @default.
• W4315487395 creator A5022670020 @default.
• W4315487395 creator A5032732071 @default.
• W4315487395 creator A5051746576 @default.
• W4315487395 creator A5055196754 @default.
• W4315487395 creator A5069443547 @default.
• W4315487395 creator A5079149569 @default.
• W4315487395 creator A5081853954 @default.
• W4315487395 creator A5081900779 @default.
• W4315487395 date "2023-01-11" @default.
• W4315487395 modified "2023-10-15" @default.
• W4315487395 title "HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer" @default.
• W4315487395 cites W1021223646 @default.
• W4315487395 cites W1594462887 @default.
• W4315487395 cites W1963481639 @default.
• W4315487395 cites W1973594634 @default.
• W4315487395 cites W1996102081 @default.
• W4315487395 cites W2025475845 @default.
• W4315487395 cites W2040618598 @default.
• W4315487395 cites W2050817546 @default.
• W4315487395 cites W2075294566 @default.
• W4315487395 cites W2123106337 @default.
• W4315487395 cites W2147551134 @default.
• W4315487395 cites W2165115006 @default.
• W4315487395 cites W2199255753 @default.
• W4315487395 cites W2411930788 @default.
• W4315487395 cites W2465082576 @default.
• W4315487395 cites W2472156661 @default.
• W4315487395 cites W2525543622 @default.
• W4315487395 cites W2557658326 @default.
• W4315487395 cites W2763822466 @default.
• W4315487395 cites W2782582399 @default.
• W4315487395 cites W2791031844 @default.
• W4315487395 cites W2792620646 @default.
• W4315487395 cites W2886498337 @default.
• W4315487395 cites W2889377217 @default.
• W4315487395 cites W2928824309 @default.
• W4315487395 cites W2946918497 @default.
• W4315487395 cites W2954120568 @default.
• W4315487395 cites W2966019641 @default.
• W4315487395 cites W2974786970 @default.
• W4315487395 cites W3015939962 @default.
• W4315487395 cites W3022353914 @default.
• W4315487395 cites W3026631838 @default.
• W4315487395 cites W3037857867 @default.
• W4315487395 cites W3041331093 @default.
• W4315487395 cites W3080273502 @default.
• W4315487395 cites W3091202129 @default.
• W4315487395 cites W3118826114 @default.
• W4315487395 cites W3158213854 @default.
• W4315487395 cites W3167888403 @default.
• W4315487395 cites W3186222380 @default.
• W4315487395 cites W3195406213 @default.
• W4315487395 cites W3209942528 @default.
• W4315487395 cites W3210060114 @default.
• W4315487395 cites W4210990885 @default.
• W4315487395 cites W4225320727 @default.
• W4315487395 doi "https://doi.org/10.3389/fphar.2022.1096055" @default.
• W4315487395 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36712672" @default.
• W4315487395 hasPublicationYear "2023" @default.
• W4315487395 type Work @default.
• W4315487395 citedByCount "1" @default.
• W4315487395 countsByYear W43154873952023 @default.
• W4315487395 crossrefType "journal-article" @default.
• W4315487395 hasAuthorship W4315487395A5005196775 @default.
• W4315487395 hasAuthorship W4315487395A5007290715 @default.
• W4315487395 hasAuthorship W4315487395A5009380236 @default.
• W4315487395 hasAuthorship W4315487395A5022499603 @default.
• W4315487395 hasAuthorship W4315487395A5022670020 @default.
• W4315487395 hasAuthorship W4315487395A5032732071 @default.
• W4315487395 hasAuthorship W4315487395A5051746576 @default.
• W4315487395 hasAuthorship W4315487395A5055196754 @default.
• W4315487395 hasAuthorship W4315487395A5069443547 @default.
• W4315487395 hasAuthorship W4315487395A5079149569 @default.
• W4315487395 hasAuthorship W4315487395A5081853954 @default.
• W4315487395 hasAuthorship W4315487395A5081900779 @default.
• W4315487395 hasBestOaLocation W43154873951 @default.
• W4315487395 hasConcept C104317684 @default.
• W4315487395 hasConcept C119857082 @default.
• W4315487395 hasConcept C121608353 @default.
• W4315487395 hasConcept C126322002 @default.
• W4315487395 hasConcept C136764020 @default.
• W4315487395 hasConcept C143998085 @default.
• W4315487395 hasConcept C150194340 @default.
• W4315487395 hasConcept C161584116 @default.
• W4315487395 hasConcept C172512520 @default.
• W4315487395 hasConcept C199163554 @default.
• W4315487395 hasConcept C2779733811 @default.
• W4315487395 hasConcept C34626388 @default.
• W4315487395 hasConcept C37616216 @default.
• W4315487395 hasConcept C41008148 @default.
• W4315487395 hasConcept C50382708 @default.
• W4315487395 hasConcept C54355233 @default.
• W4315487395 hasConcept C58471807 @default.
• W4315487395 hasConcept C60644358 @default.

• next